2Zellner C, Protter AA, Ko E, et al. Coronary vasodilator effects of BNP.. mechanisms of action in coronary conductance and resistance arteries [J]. AmJ Physiol, 1999, 276 (3): 149--157. 被引量：1
3Michaels AD, Klein A, Madden JA, et al. Effects of intravenousnesiritide on human coronary vasomotor regulation and myocardial oxygen uptake [J].Circulation, 2003, 107(21):269-270. 被引量：1
4BurgerAJ, Horton DP, LeJemtel T, et al. Effect of nesiritide (B2 type natriuretic pep tide) and dobu- tamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure., the PRECEDENT study [J] . Am Heart J, 2002,144(6) :102-108. 被引量：1
5Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic pep tide in patients with hemodynamically decompensated heart failure[J]. J Card Fail, 1998, 4(1) :37-44. 被引量：1
6Cao L, Gardner DG. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts[J]. Hypertension, 1995, 25(2): 227-234. 被引量：1
7Kawakami R,Saito Y,Kishimoto I , et al . Over expression of brain natriuretic peptide facilitates neu- trophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction [J]. Circulation ,2004 ,110(21) :3306--3312. 被引量：1
8Karl S, John C,Wlson S, et al. Guidelines for the diagnosis and treatment of chronic heart failure: ex- ecutivesummary[J]. Eur Heart J, 2005, 26 (6) 1115-1140. 被引量：1
9Colucci WS, Elkayam U, Horton DP, et al. Intravenous neSiritide,a natriuretic pep tide, in the treatment of decompensated congestive: heart failure . Nesiritide Study Group[J]. N Engl J Med, 2000,343(4):246--253. 被引量：1
10Emerman CL. Safety and efficacy of nesiritide for the treatment of decompensated heart failure [J]. Rev Cardiovasc Med, 2002, 3 (Suppl 4):S28-34. 被引量：1
